Literature DB >> 1777603

A C----G mutation at nt position 6 3' to the terminating codon may be the cause of a silent beta-thalassemia.

L Jankovic1, A J Dimovski, P Kollia, M Karageorga, D Loukopoulos, T H Huisman.   

Abstract

We describe the hematological and clinical data for a young Greek patient with beta-thalassemia intermedia and for several members of her family. The patient had inherited the common IVS-I-1 (G----A) mutation from her mother, while the second beta-globin gene had a C----G mutation at position 6 3' to the terminating codon (term. + 6). Her father and three additional relatives with a heterozygosity for this newly discovered mutation had no hematological abnormalities, normal Hb A2 values, and a nearly normal in vitro chain synthesis ratio. Analyses of nearly 500 additional beta-thalassemia and normal chromosomes failed to detect this mutation which eliminates it as a common polymorphism. Although our findings may indicate a rare polymorphism, the probability that it represents the cause of diminished beta chain synthesis is very high indeed. We suggest that the C----G mutation in this untranslated region of the beta-globin gene causes a slight decrease in the stability of the mRNA which becomes clinically important only in situations when beta chain synthesis in trans is eliminated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777603

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  6 in total

1.  A nucleolin-binding 3' untranslated region element stabilizes beta-globin mRNA in vivo.

Authors:  Yong Jiang; Xiang-Sheng Xu; J Eric Russell
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 2.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

3.  Searching for potential microRNA-binding site mutations amongst known disease-associated 3' UTR variants.

Authors:  Nadia Chuzhanova; David N Cooper; Claude Férec; Jian-Min Chen
Journal:  Genomic Med       Date:  2007-01-30

Review 4.  Control of human beta-globin mRNA stability and its impact on beta-thalassemia phenotype.

Authors:  Isabel Peixeiro; Ana Luísa Silva; Luísa Romão
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

5.  Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA.

Authors:  J Yu; J E Russell
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Spectrum of HBB gene mutations among 696 β-thalassemia patients and carriers in Southern Vietnam.

Authors:  Phan Thị Xinh; Ho Quoc Chuong; Nguyen Thi Thanh Ha; Huynh Duong Bich Tram; Cao Van Dong; Le Vu Ha Thanh; Nguyen Thi Hong Hoa; Huynh Nghia; Nguyen Tan Binh; Phu Chi Dung; Hoang Anh Vu
Journal:  Mol Biol Rep       Date:  2022-01-13       Impact factor: 2.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.